2003
DOI: 10.1016/s0896-6273(03)00301-5
|View full text |Cite
|
Sign up to set email alerts
|

Unique Role of Dystroglycan in Peripheral Nerve Myelination, Nodal Structure, and Sodium Channel Stabilization

Abstract: Dystroglycan is a central component of the dystrophin-glycoprotein complex implicated in the pathogenesis of several neuromuscular diseases. Although dystroglycan is expressed by Schwann cells, its normal peripheral nerve functions are unknown. Here we show that selective deletion of Schwann cell dystroglycan results in slowed nerve conduction and nodal changes including reduced sodium channel density and disorganized microvilli. Additional features of mutant mice include deficits in rotorod performance, aberr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
227
0
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 223 publications
(239 citation statements)
references
References 61 publications
11
227
0
1
Order By: Relevance
“…[38][39][40] Admittedly, loss of the entire dystroglycan protein might have effects beyond those caused by defects in its glycosylation, but these data nevertheless support the possibility that all glycosylation defects in the dystroglycanopathies could be centered on dystroglycan. This characterization represents the current state of the literature.…”
Section: Glycosylation Of Dystroglycanmentioning
confidence: 89%
“…[38][39][40] Admittedly, loss of the entire dystroglycan protein might have effects beyond those caused by defects in its glycosylation, but these data nevertheless support the possibility that all glycosylation defects in the dystroglycanopathies could be centered on dystroglycan. This characterization represents the current state of the literature.…”
Section: Glycosylation Of Dystroglycanmentioning
confidence: 89%
“…Von Frey filaments of varying bending forces (1.5, 0.7, 0.3, 0.2, 0.08 mN) were applied 10 times to the each plantar surface of the hindpaw and the number of withdrawals was recorded. 36 The mechanical withdrawal threshold was measured before the first run (day -1), before injection 1 (day 0), before the third run (day 4), before injection 2 (day 5), and 24 hours after the second injection (day 6) (Fig 1). In the current study, we interpreted an increase in the number of withdrawals as cutaneous hyperalgesia of the paw.…”
Section: Mechanical Withdrawal Response Of the Pawmentioning
confidence: 99%
“…De leur côté, des mutations récessives du gène prx, codant pour la périaxine, ont été associées chez l'homme à deux types de neuropathies démyélinisantes héréditaires, une forme 4F de CMT et le syndrome récessif de Dejerine-Sottas (DSS) [18,19]. Par ailleurs, les souris dont le gène codant pour le dystroglycane dans les cellules de Schwann a été invalidé montrent une désorganisation importante des microvillosités au niveau des noeuds de Ranvier, une diminution de la densité de canaux Na + et un repliement de la myéline [20]. Le dystroglycane-α semble égale-ment être le récepteur de Mycobacterium leprae, un pathogène intracellulaire des cellules de Schwann qui induit une neuropathie périphérique [21].…”
Section: Connexion De La Cellule De Schwann à Sa Lame Basaleunclassified